Descrizione del progetto
Un catetere attivo innovativo per procedure endovascolari
Le procedure endovascolari comportano il passaggio attraverso il sistema vascolare mediante l’introduzione di un catetere nell’arteria della gamba o del braccio di un paziente e il suo indirizzamento fino all’area di trattamento. Le soluzioni attuali utilizzano cateteri passivi instradati lungo guide flessibili, che presentano problemi di prestazioni in caso di anatomie vascolari complesse. L’azienda francese Basecamp Vascular sta sviluppando un dispositivo medico innovativo come guida del catetere attiva e regolabile, in grado di adattarsi alle variazioni anatomiche individuali del paziente. La prima versione di questo dispositivo è stata realizzata per l’approvazione normativa e clinica per la successiva commercializzazione. Il progetto MULTICURVE, finanziato dall’UE, intende contribuire all’ottimizzazione della strategia aziendale per l’accesso al mercato.
Obiettivo
While endovascular procedures have grown very quickly in the past years, notably for the treatment of neurovascular pathologies, they may be impossible to implement when navigation is complicated by high vessels tortuosities or bifurcations angulations. In such cases, medical practitioners have no choice but to use alternative techniques, often complex and costly.
Basecamp Vascular (BCV), a French SME created in 2016, is focused on the development and commercialisation of a breakthrough medical device: the first ever mechatronic active catheter dedicated to endovascular navigation in any anatomy, even complex, for neurovascular pathologies. BCV aims at providing the world market of endovascular procedures, specifically the “endovascular access” segment (+/- 8 million procedures / year, €5 billion in value), with this device, which tip can be modified on-demand as opposed to current passive catheters which preformed curve is unchangeable. First commercialisation is planned by 2019, with a first focus on the EU area, to be addressed globally as soon as the EC marking is obtained.
A first version (mono-curve) of BCV active catheter has been developed and validated and the upgraded version of the device (multi-curve) is currently in development and will be achieved by the end of 2017. In this frame, the MULTICURVE SME Instrument project aims at optimally preparing future innovation steps, with three specific objectives for phase 1: refining the current market strategy, preparing regulatory markings and preparing the planned multicentric, transnational clinical study to be performed in phase 2.
As such, the SME Instrument support will facilitate reaching the market of endovascular procedures, the multi-curve device being an unprecedented solution for medical practitioners. Indeed, for the first time, they should benefit from a catheter able to adjust to all patients’ individual anatomical variations, thus fully fitting within the personalised medicine concept.
Campo scientifico
Programma(i)
- H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme
- H2020-EU.2.1.5. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing
- H2020-EU.2.1.3. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SMEINST-1-2016-2017
Meccanismo di finanziamento
SME-1 - SME instrument phase 1Coordinatore
51100 REIMS
Francia
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.